Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Non-Current Assets (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Non-Current Assets readings, the most recent being $263.0 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 8.14% to $263.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 billion, a 21.24% increase, with the full-year FY2025 number at $263.0 million, up 8.14% from a year prior.
  • Non-Current Assets hit $263.0 million in Q4 2025 for Tandem Diabetes Care, up from $257.7 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $263.0 million in Q4 2025 to a low of $92.6 million in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $203.5 million (2022), compared with a mean of $192.8 million.
  • Biggest five-year swings in Non-Current Assets: soared 123.66% in 2022 and later decreased 14.75% in 2023.
  • Tandem Diabetes Care's Non-Current Assets stood at $93.6 million in 2021, then skyrocketed by 116.64% to $202.8 million in 2022, then rose by 0.92% to $204.7 million in 2023, then grew by 18.81% to $243.2 million in 2024, then increased by 8.14% to $263.0 million in 2025.
  • The last three reported values for Non-Current Assets were $263.0 million (Q4 2025), $257.7 million (Q3 2025), and $260.9 million (Q2 2025) per Business Quant data.